Related Experiment Video
Updated: Sep 28, 2025

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Functional diversity in the RAS subfamily of small GTPases
Gabriela Bernal Astrain1, Maya Nikolova1, Matthew J Smith1,2
1Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Abstract:
RAS small GTPases regulate important signalling pathways and are notorious drivers of cancer development and progression. While most research to date has focused on understanding and addressing the oncogenic potential of three RAS oncogenes: HRAS, KRAS, and NRAS; the full RAS subfamily is composed of 35 related GTPases with diverse cellular functions. Most remain deeply understudied despite strong evolutionary conservation. Here, we highlight a group of 17 poorly characterized RAS GTPases that are frequently down-regulated in cancer and evidence suggests may function not as oncogenes, but as tumour suppressors. These GTPases remain largely enigmatic in terms of their cellular function, regulation, and interaction with effector proteins. They cluster within two families we designate as 'distal-RAS' (D-RAS; comprised of DIRAS, RASD, and RASL10) and 'CaaX-Less RAS' (CL-RAS; comprised of RGK, NKIRAS, RERG, and RASL11/12 GTPases). Evidence of a tumour suppressive role for many of these GTPases supports the premise that RAS subfamily proteins may collectively regulate cellular proliferation.
Insights
This study explores understudied RAS GTPases, revealing 17 may act as tumor suppressors, not oncogenes. These proteins, frequently downregulated in cancer, offer new therapeutic targets for cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Signaling
Background:
- RAS small GTPases are key regulators of cellular signaling pathways and are implicated in cancer development.
- Research has primarily focused on oncogenic RAS genes (HRAS, KRAS, NRAS), neglecting other subfamily members.
- The RAS subfamily comprises 35 GTPases with diverse functions, many of which remain understudied.
Purpose of the Study:
- To investigate the role of understudied RAS GTPases in cancer.
- To identify RAS GTPases that may function as tumor suppressors.
- To characterize two novel families of RAS GTPases: distal-RAS (D-RAS) and CaaX-Less RAS (CL-RAS).
Main Methods:
- Bioinformatic analysis of RAS GTPase expression in cancer datasets.
- Literature review of existing evidence on understudied RAS GTPases.
- Classification of identified RAS GTPases into functional families.
Main Results:
- Identified 17 poorly characterized RAS GTPases frequently downregulated in cancer.
- Evidence suggests these GTPases function as tumor suppressors, contrasting with known oncogenic RAS.
- These GTPases cluster into two families: D-RAS (DIRAS, RASD, RASL10) and CL-RAS (RGK, NKIRAS, RERG, RASL11/12).
Conclusions:
- Understudied RAS GTPases, particularly those in the D-RAS and CL-RAS families, show potential as tumor suppressors.
- The RAS subfamily may collectively regulate cellular proliferation, with both oncogenic and tumor-suppressive members.
- Further research into these enigmatic GTPases is warranted for understanding cancer biology and developing novel therapies.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
GTPases and their Regulation
Large G-proteins,...
Rab Cascades
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Activation and Inactivation of G Proteins

